European Parliament Urges Increased Role For Generics And Biosimilars

Industry Welcomes Call For A ‘Greater Market Presence’ For Off-Patent Drugs

 
• By David Wallace
  
European parliament chamber
The European Parliament has adopted a report urging a greater presence for generics and biosimilars • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin